Barry S. Weinstock
Orlando Regional Medical Center
6 Papers
Barry S. Weinstock is an academic researcher from Orlando Regional Medical Center. The author has contributed to research in topics: Renal artery & Atherectomy. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
Gregory Piazza,Benjamin Hohlfelder,Michael R. Jaff,Kenneth Ouriel,Tod C. Engelhardt,Keith M. Sterling,Noah Jones,John C. Gurley,Rohit Bhatheja,Robert J. Kennedy,Nilesh J. Goswami,Kannan Natarajan,John H. Rundback,Immad Sadiq,Stephen K. Liu,Narinder Bhalla,M. Laiq Raja,Barry S. Weinstock,Jacob Cynamon,Fakhir Elmasri,Mark J. Garcia,Mark H. Kumar,Juan Ayerdi,Peter A. Soukas,William T. Kuo,Ping-Yu Liu,Samuel Z. Goldhaber,Seattle Ii Investigators +27 more
TL;DR: Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis decreased RV dilation, reduced pulmonary hypertension, decreased anatomic thrombus burden, and minimized intracranial hemorrhage in patients with acute massive and submassive PE.
795
Nine-month results of the REFORM study: a prospective, single-arm, multicenter clinical study of the safety and effectiveness of the Formula™ balloon-expandable stent for treatment of renal artery stenosis.
Robert M. Bersin,Gary M. Ansel,Anthony Rizzo,H. Bob Smouse,Shantanu Sinha,Ravish Sachar,Rajesh Dave,Barry S. Weinstock,Robert L. Feldman,Gary S. Roubin +9 more
TL;DR: The 9‐month safety and effectiveness outcomes of the Formula™ balloon‐expandable renal stent for the treatment of atherosclerotic renal artery stenosis (RAS) following suboptimal angioplasty are evaluated.
47
Safety and performance of targeted renal therapy: the Be-RITe! Registry.
Giora Weisz,Steven J. Filby,Mauricio G. Cohen,David E. Allie,Barry S. Weinstock,Dimitris K. Kyriazis,Craig M. Walker,Jeffrey W. Moses,Paolo Danna,William F. Fearon,Naveen Sachdev,Bret N. Wiechmann,Kishor Vora,Laura K. Findeiss,Matthew J. Price,Roxana Mehran,Martin B. Leon,Paul S. Teirstein +17 more
TL;DR: The Benephit system and TRT during coronary and endovascular procedures in patients at high risk for renal failure is simple to use and safe and with the infusion of intrarenal fenoldopam, the incidence of CIN was significantly lower than predicted by risk score calculations.
44
Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry.
Rajesh Dave,Raghotham R. Patlola,Kenneth Kollmeyer,Frank Bunch,Barry S. Weinstock,Eric J. Dippel,Michael R. Jaff,Jeffrey J. Popma,Neil J. Weissman +8 more
TL;DR: The data validate the safety and efficacy of the CliRpath Excimer Laser System to Enlarge Lumen Openings, with a high clinical success rate and 12-month data indicating freedom from reintervention in the majority of patients treated.
Novel laser‐based catheter for peripheral atherectomy: 6‐month results from the Eximo Medical B‐Laser™ IDE study
John H. Rundback,Pradeep Chandra,Marianne Brodmann,Barry S. Weinstock,Gino Sedillo,Ian Cawich,Antonio Micari,Arthur Lee,Chris Metzger,Luis Mariano Palena,Nicolas W. Shammas +10 more
TL;DR: The B‐Laser™ atherectomy system is a 355 nm solid‐state Nd:YAG short pulse laser for de‐novo and restenotic infrainguinal PAD with enhanced affinity for atheroma and calcified plaque.